Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97%
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panacea Biotec Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Other Operating Expenses
-â‚ą2B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Other Operating Expenses
-â‚ą59.8m
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
12%
Transgene Biotek Ltd
BSE:526139
Other Operating Expenses
-â‚ą7.4m
CAGR 3-Years
-29%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Other Operating Expenses
-â‚ą146.5m
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-26%
Hester Biosciences Ltd
NSE:HESTERBIO
Other Operating Expenses
-â‚ą956m
CAGR 3-Years
-18%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Other Operating Expenses
-â‚ą38.1B
CAGR 3-Years
-37%
CAGR 5-Years
-25%
CAGR 10-Years
-22%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Other Operating Expenses?
Other Operating Expenses
-2B INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Other Operating Expenses amounts to -2B INR.

What is Panacea Biotec Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
4%

Over the last year, the Other Operating Expenses growth was -18%. The average annual Other Operating Expenses growth rates for Panacea Biotec Ltd have been 4% over the past three years , 4% over the past five years .

Back to Top